3-51391710-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_013286.5(RBM15B):c.311G>T(p.Gly104Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000298 in 1,375,730 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_013286.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBM15B | NM_013286.5 | c.311G>T | p.Gly104Val | missense_variant | 1/1 | ENST00000563281.2 | NP_037418.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBM15B | ENST00000563281.2 | c.311G>T | p.Gly104Val | missense_variant | 1/1 | NM_013286.5 | ENSP00000454545 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000332 AC: 5AN: 150722Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000588 AC: 1AN: 17000Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 10222
GnomAD4 exome AF: 0.0000294 AC: 36AN: 1225008Hom.: 0 Cov.: 31 AF XY: 0.0000285 AC XY: 17AN XY: 597078
GnomAD4 genome AF: 0.0000332 AC: 5AN: 150722Hom.: 0 Cov.: 32 AF XY: 0.0000272 AC XY: 2AN XY: 73520
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 05, 2022 | The c.311G>T (p.G104V) alteration is located in exon 1 (coding exon 1) of the RBM15B gene. This alteration results from a G to T substitution at nucleotide position 311, causing the glycine (G) at amino acid position 104 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at